CD8+ TILs and Breast Cancer: Identifying New Opportunities for Immunotherapeutic Intervention
In this webinar, Dr. Egelston discusses recent efforts to isolate and characterize phenotypically and functionally exhausted CD8+ TILs from a subset of breast tumors.
Publish Date:
August 30, 2019